VolitionRx Limited, a life
sciences company focused on developing blood-based diagnostic tests for
different types of cancer, this morning told investors that the company
presented at the 2nd annual MicroCapClub Invitational. The company’s
presentation can be accessed at the following link:
http://microcapclub.com/2014/01/microcapclub-invitational-volitionrx-vnrx/
“At MicroCapClub we have 147
experienced microcap investors discussing over 180 microcap companies in our
members forum. We handpick several unique companies every year to showcase to
the public,” said Ian Cassel, founder of MicroCapClub. “We have been following
VolitionRx since it went public a couple years ago and believe the company is
now at an interesting inflection point. If the company’s blood based cancer
diagnostic platform is successfully validated through large clinical trials in
2014, it will be a game changer for the cancer arena and shareholders. Given
the company’s current valuation compared to its peer group, we feel VolitionRx
is worth following.”
“We have an exciting year
coming up,” says Cameron Reynolds, CEO of VolitionRx. “On the clinical side, we
expect to publish initial results from our first major 4,800-individual
colorectal cancer diagnostic trial, and begin the application process for
European CE regulatory approval. We also expect to book significant early
revenue from our epigenetic Research Use Kits, which will assist the company in
funding our ongoing trials.”
For more information on
VolitionRx, visit www.VolitionRx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
